The World Pharma Pricing and Market Access Congress is Europe’s largest market access and pricing conference. Bringing together industry leaders from pharma companies, payers and HTAs, PPMA provides excellent opportunities to hear from patient led organisations, healthcare providers and other industry bodies.
The 2020 edition features dedicated tracks on Evidence (including Real World Evidence), Big Data, Digital Health & Analytics, Value, Pricing & Market Access, Affordability, Contracting, as well as a focus on therapeutic areas including Rare Diseases, Advanced Therapies, BioSimilar, and more…
It’s about getting the right drug, to the right patient, at the right cost and achieving maximum reimbursement success.
With over 500 attendees already confirmed including many global heads of pricing, access, evidence & RWE this edition is looking to be our biggest and best yet.
This year we have worked hard on creating the most diverse agenda which involves:
- 50+ Payers/HTA’s in attendance including NICE, G-BA & EUnetHTA
- 35 + roundtables
- 7 tracks
- Over 30 small to medium pharma/biotech companies represented
- Greater markets covered globally including Ukraine, Turkey & Singapore